CCND1 and colorectal carcinoma: Treatment with all the NSAIDs, except rofecoxib, was associated with a marked decrease in cyclin D1 protein levels, such that there was a complete absence of cyclin D1 protein in SW480 human CRC cells after treatment with high (>200 μM) concentrations of NSAIDs (Figure 3A–E).